current regulatory requirements to conduct clinical research in India
Download as PPTX, PDF0 likes105 views
this ppt gives an outline to prepare on the topic of current regulatory requirements to conduct clinical research in India
More Related Content
Similar to current regulatory requirements to conduct clinical research in India (20)
More from Chiru Uday (7)
Recently uploaded (20)
current regulatory requirements to conduct clinical research in India
- 1. "Current Regulatory Requirements for Conducting Clinical Research in India" Template to prepare ppt on this topic Dr. Uday
- 2. 1. Introduction Briefly explain how clinical research helps develop new drugs, improve existing treatments, and advance medical knowledge. Highlight the growing importance of India as a clinical trial hub due to factors like diverse population and robust healthcare infrastructure. Briefly mention the regulatory framework that ensures the safety, ethical conduct, and scientific validity of clinical research in India.
- 4. 2. Regulatory Authority and Guidelines Central Drugs Standard Control Organization (CDSCO) is the apex body responsible for regulating clinical trials in India. Drugs and Cosmetics Act (1940) is the foundational legislation governing drugs and clinical trials. The New Drugs and Clinical Trials Rules (2019) is the most recent and comprehensive set of regulations outlining the specific requirements for conducting clinical trials. International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines is the international ethical and scientific quality standard for clinical research. Compliance with these guidelines is mandatory for all clinical trials conducted in India.
- 5. 3. Key Requirements for Conducting Clinical Trials Application process for conducting a clinical trial in India. Includes obtaining approvals from the CDSCO, Ethics Committees (ECs) associated with the trial sites, and the Drug Advisory Committee (DAC) (for certain types of trials).
- 6. Informed consent process Importance of providing participants with clear and complete information about the trial, potential risks and benefits, and their right to withdraw at any time.
- 7. Data management and reporting requirements Maintaining accurate and complete records of the trial, submitting periodic safety reports to the CDSCO and ECs, and reporting all Serious Adverse Events (SAEs) promptly.
- 8. 4. Recent Developments and Initiatives Recent changes or advancements in the regulatory landscape. Include new guidelines issued by the CDSCO, initiatives to streamline the approval process, or emphasis on specific therapeutic areas. Initiatives aimed at promoting clinical research in India, such as faster approvals, online portals for submissions,or capacity building programs for clinical research professionals.
- 9. 5. Conclusion Summarize the key points about the current regulatory requirements, emphasizing the importance of a robust regulatory framework for protecting participants and ensuring the integrity of research. Importance of adhering to these regulations for conducting ethical and successful clinical research that contributes to medical progress.
- 10. Bonus Consider adding a slide on the specific regulatory pathways for different types of clinical trials (e.g., Investigator-initiated trials vs. industry-sponsored trials). Each pathway might have slightly different application procedures and approval requirements. Include resources for further information, such as the CDSCO website (https://cdsco.gov.in/opencms/opencms/en/Home/),relevant publications from the ICMR, or professional organizations like the Indian Society for Clinical Research (ISCR) https://www.iscr.org/.